fundvisualizer.com

Nuveen International Eq Idx ITCIHX

Performance (before sales charge)

As of 06/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 05/31/2024
Stock
0.55%
Non-U.S. Stock
96.91%
Bond
0.34%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.99%
Other
0.21%

Due to rounding, percentages may not equal 100%.

Sectors

As of 05/31/2024

Basic materials

6.58%

Consumer cyclical

10.43%

Financial services

18.59%

Real estate

2.18%

Consumer defensive

8.36%

Health care

12.78%

Utilities

2.83%

Communication services

4.34%

Energy

4.17%

Industrials

16.45%

Technology

9.50%

Top 10 holdings

As of 05/31/2024

Novo Nordisk A/S Class B
2.53%
ASML Holding NV
2.19%
Nestle SA
1.62%
AstraZeneca PLC
1.36%
Shell PLC
1.33%
Toyota Motor Corp
1.32%
Lvmh Moet Hennessy Louis Vuitton SE
1.26%
Msci Eafe Jun24 Ifus 20240621
1.19%
Novartis AG Registered Shares
1.17%
SAP SE
1.09%
Fund assets

$24.63 Billion

Share class

Inst

Morningstar category

Foreign Large Blend

Expense ratio

0.19%

Investment objective

Foreign Stock

Documents